Benyamin R,Trescot A M,Datta S,et al. Opioid complica-tions and side effects[J]. Pain Physician,2008,11 (2 Sup-pl) : S105 - S120.
[4]
Manchikanti L,Vallejo R,Manchikanti K N,et al. Effective-ness of long-term opioid therapy for chronic non-cancer pain[J]. Pain Physician,2011,14(2):E133-E156.
[5]
Chapman C R,Lipschitz D L,Angst M S,et al. Opioid pharma-cotherapy for chronic non-cancer pain in the United States:a research guideline for developing an evidence-base[J].J Pain,2010,11(9):807-829.
[6]
Jennings E M, Okine B N, Roche M, et al.Stress-induced hyperalgesia.[J].Prog Neurobiol, 2014, 121:1-18.
[7]
Lä Y F, Yang Y, Li C L, et al.The Locus Coeruleus-Norepinephrine System Mediates Empathy for Pain through Selective Up-Regulation of P2X3 Receptor in Dorsal Root Ganglia in Rats[J].Front Neural Circuits, 2017, 11:66.
[8]
Correa-Sales C, Rabin B C, Maze M.A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.[J].Anesthesiology, 1992, 76(6):948-952.
[9]
Tamagaki S, Suzuki T, Hagihira S, et al.Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn.[J].J Pharm Pharmacol, 2010, 62(12):1760.
[10]
Pirbudak L, Maralcan G.Pain management with intrathecal clonidine in a colon cancer patient with opioid hyperalgesia: case presentation.[J].Agri.2014, 26(2):93-96.
Jo J Y, Choi S S, Yi J M, et al.Differential Postoperative Effects of Volatile Anesthesia and Intraoperative Remifentanil Infusion in 7511 Thyroidectomy Patients: A Propensity Score Matching Analysis[J].Medicine, 2016, 95(7):e2764.
Lee C, Kim Y D, Kim J N.Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia[J].Korean J Anesthesiol, 2013, 64(4):301-307.
[17]
Zheng Y, Cui S, Liu Y, et al.Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit[J].Brain Res Bull, 2012, 87(4-5):427.
Yamakita S, Matsuda M, Yamaguchi Y, et al.Dexmedetomidine prolongs levobupivacaine analgesia via inhibition of inflammation and p38 MAPK phosphorylation in rat dorsal root ganglion [J].Neuroscience, 2017, 361:58.
[22]
Zheng Y, Cui S, Liu Y, et al.Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit.[J].Brain Res Bull, 2012, 87(4-5):427.
[23]
Lu Y,Lin B,Zhong J.The therapeutic effect of dexmedetomidine on rat diabetic neuropathy pain and the mechanism.[J].Biol Pharm Bull, 2017,40(9):1432-1438.
[24]
Faber ESL,Chambers J P,Evans R H.Depression of NMDA receptor-mediated synaptic trasmission by four a2 adrenoceptor agonists on the in vitro rat spinal cord preparation [J],Br J Phamaco,1998,124(3):507-512.
[25]
Yuan Y, Zhe S, Yi C,et al.Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro[J].Plos One, 2017, 12(2):e0171348.
2018, Vol. 29 
